Hamilton James C bought ARWR
January 4, 2024 · Form 4 insider transaction
Hamilton James C bought 75,000 shares of Arrowhead Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
75,000
Price
$0.00
Total value
N/A
InsiderHamilton James C
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 4, 2024
Filing dateJanuary 5, 2024
Shares owned after250,934
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares underlying restricted stock units with a grant date 01/04/24, which will vest in four equal annual installments.